Epithalon (also referred to as Epitalon) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly. It was developed as a synthetic analogue of Epithalamin, an endogenous polypeptide fraction isolated from the pineal gland by researchers at the Saint Petersburg Institute of Bioregulation and Gerontology. Epithalon has been the subject of research spanning several decades, with investigations focused primarily on its interactions with telomerase activity, neuroendocrine regulation, and cellular ageing mechanisms. Researchers looking to source Epithalon for laboratory use can view our Longevity & Anti-Ageing research compounds or browse the full research compound catalogue.
Structural Profile
Epithalon consists of four amino acids: alanine (Ala), glutamic acid (Glu), aspartic acid (Asp), and glycine (Gly). Its molecular formula is C₁₄H₂₂N₄O₉ with a molecular weight of approximately 390.35 g/mol. The compound is water-soluble and typically supplied in lyophilised form for research purposes. Its short sequence and high water solubility make it relatively straightforward to reconstitute and work with in laboratory settings compared to longer or more hydrophobic peptides.
Synthesis and Manufacturing
Epithalon is produced through solid-phase peptide synthesis (SPPS), the standard methodology for manufacturing short research peptides. In SPPS, amino acids are sequentially coupled to a solid resin support, building the peptide chain from the C-terminus to the N-terminus. Following synthesis, the peptide is cleaved from the resin, purified by HPLC, and lyophilised. Research-grade Epithalon should be accompanied by a Certificate of Analysis confirming purity, typically ≥98% by HPLC, and molecular weight confirmation by mass spectrometry.
Research Applications
Telomerase Activity
The most extensively investigated area of Epithalon research concerns its apparent interaction with telomerase, the enzyme responsible for maintaining telomere length during cell division. A foundational study by Khavinson et al. (2003) reported that adding Epithalon to telomerase-negative human fetal fibroblast cultures induced expression of the catalytic subunit of telomerase (hTERT), increased telomerase enzymatic activity, and produced measurable telomere elongation — with treated cultures continuing to proliferate beyond the normal Hayflick limit.
More recently, a 2025 study published in Biogerontology by Al-Dulaimi et al. investigated Epithalon’s effects across multiple human cell lines, including breast cancer lines and normal epithelial and fibroblast cells. The study reported telomere length increases via two distinct pathways — telomerase upregulation in normal cells and alternative lengthening of telomeres (ALT) in cancer cell lines — providing a more detailed mechanistic picture of how Epithalon may exert its observed effects across different cell types. Researchers interested in the broader context of cellular ageing and telomere biology may also find our article on GHK-Cu recent research relevant, given overlapping interests in longevity pathway investigation.
Neuroendocrine and Pineal Regulation
As a synthetic analogue of a pineal gland-derived peptide, Epithalon has been studied in the context of neuroendocrine regulation. Research has examined its effects on melatonin secretion patterns and circadian rhythm-associated parameters in animal models, with some studies reporting apparent normalisation of age-related disruptions to these systems. A 2025 PMC review notes that Epithalon was first identified in a pineal gland extract and is based on the endogenous polypeptide Epithalamin, providing context for its proposed neuroendocrine interactions.
Antioxidant Pathway Research
Several preclinical studies have examined Epithalon’s interactions with antioxidant defence systems, including superoxide dismutase and catalase activity. Researchers have reported apparent upregulation of endogenous antioxidant activity in animal models, which has been proposed as a contributing mechanism to the compound’s observed effects in ageing-related research. These antioxidant properties have also been studied in the context of neuroprotection, with research suggesting potential relevance to oxidative stress models of neurodegeneration.
Current State of the Literature
The majority of published Epithalon research originates from Russian and Eastern European research institutions, particularly the Saint Petersburg Institute of Bioregulation and Gerontology. While the volume of preclinical and some observational data is notable for a peptide of this length, independent replication outside the originating research group remains limited. As noted in a critical review on the Peptide Protocol Wiki, no independent laboratory has fully replicated the telomerase activation findings, and no registered human clinical trials have been completed with published results meeting modern trial standards. Researchers should weigh these limitations when evaluating the existing evidence base.
For researchers exploring related longevity compounds, our articles on BPC-157 mechanisms of action and GHK-Cu recent research findings provide additional context on preclinical peptide research. You can also browse our full research hub for further articles.
Key Takeaways
- Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed as an analogue of the endogenous pineal peptide Epithalamin.
- Primary research areas include telomerase activation, neuroendocrine modulation, and antioxidant pathway interaction in preclinical models.
- A 2025 study in Biogerontology provided new mechanistic data on telomere lengthening via both telomerase upregulation and ALT pathways across multiple cell lines.
- The compound is water-soluble, synthesised via SPPS, and typically supplied lyophilised at ≥98% purity for research use.
- The existing evidence base is predominantly preclinical and concentrated within specific research institutions — independent replication remains limited.
Frequently Asked Questions
What is the difference between Epithalon and Epithalamin?
Epithalamin is a naturally occurring polypeptide fraction isolated from bovine pineal gland tissue. Epithalon is a shorter, fully synthetic tetrapeptide designed to replicate proposed active properties of Epithalamin in a more chemically defined and reproducible form suitable for research use.
How is Epithalon stored for research purposes?
Lyophilised Epithalon should be stored at -20°C in a sealed, desiccated container protected from light. Once reconstituted, solutions should be aliquoted into single-use volumes and stored at -80°C where long-term stability is required. For detailed guidance on peptide storage and reconstitution best practices, visit our research hub.
Where can researchers source Epithalon?
R&D Peptides supplies Epithalon 20mg as a research-grade compound verified by HPLC at ≥98% purity, accompanied by a Certificate of Analysis. Browse our full range of longevity research compounds or the complete product catalogue. All compounds are for laboratory research use only and are not intended for human consumption.
This content is intended for researchers and scientific professionals only. All compounds referenced are for laboratory research use exclusively and are not intended for human consumption. Nothing in this article constitutes medical advice.
